Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Improved Thermoelectrically Cooled MPPC for Photon Counting Applications

Published: Tuesday, December 24, 2013
Last Updated: Monday, December 23, 2013
Bookmark and Share
New S12576-050 and S12577-050 multi-pixel photon counter devices from Hamamatsu.

Hamamatsu Photonics have expanded and improved on their range of semi-conductor detectors, featuring photon counting capability, with the introduction of the brand new S12576-050 and S12577-050 multi-pixel photon counter devices (MPPC).

The new devices utilize a Geiger-mode avalanche photodiode structure for ultra-low-level light detection, and a two-stage thermoelectric cooler, operating down to -25°C.

The inclusion of a TE cooler reduces the MPPC dark count to 1/20 of that seen at room temperature, equating to 5cps typ. for the S12576-050 and 50cps typ. for the S12577-050.

The MPPC is easily connected to an external circuit for simple operation and is operated from a low voltage power supply (approximately 65 Volts).

Hamamatsu also offers a temperature controller which maintains a constant temperature within the thermoelectrically cooled package.

The S12576-050 and S12577-050 are 1x1mm and 3x3mm devices respectively, with 400 and 3,600 pixels. Each pixel contains a quenching resistor so that simultaneous photon events can be counted separately and, with a high degree of accuracy. The devices feature typical high gain values of 1.25E6, comparable to that achievable from a conventional photomultiplier tube.

The S12576-050 and S12577-050 are ideal for a variety of applications, including positron emission tomography, high-energy physics, DNA sequencing, fluorescence measurement, nuclear medicine, point of care systems, drug discovery, medical diagnostic equipment and environmental analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!